Quarterly report · Q3
4626.TEDINET S100Q4ZB
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥76.8bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥98.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥73.6bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥14.3bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥14.4bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥13.9bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥18.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.6bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥13.9bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥14.6bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥10.3bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.4bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥10.3bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥10.5bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥190.1bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥189.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥185.5bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥98.8bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥103.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥91.3bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥85.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥83.9bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥51.1bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥51.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥184.09 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.67 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.13 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.3 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.43 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 48.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥2.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥2.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥217m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥1m |
| jpcrp040300-q3r_E00913-000Electronics Materialsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥55.3bn |
| jpcrp040300-q3r_E00913-000Electronics Materialsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥55.3bn |
| jpcrp040300-q3r_E00913-000Electronics Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥0 |
| jpcrp040300-q3r_E00913-000Electronics Materialsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥14.2bn |
| jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥18.9bn |
| jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥18.9bn |
| jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥74.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥74.2bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥0 |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥15.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥77.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥76.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥217m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥15.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥2.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥90m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | −¥4m |
| jpcrp040300-q3r_E00913-000Electronics Materialsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥53.0bn |
| jpcrp040300-q3r_E00913-000Electronics Materialsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥53.0bn |
| jpcrp040300-q3r_E00913-000Electronics Materialsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥12.6bn |
| jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥18.1bn |
| jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥18.1bn |
| jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.5bn |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥71.1bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥71.1bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥15.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥73.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥73.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥90m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥15.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 349
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss | CurrentYTDDuration | 10319000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 263000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 103000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 1596000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 690000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -0 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -7000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 1859000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 786000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 12371000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 11106000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 12221000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 11106000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 149000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -0 | JPY |
| Trade notes receivable transferred by endorsement | Prior1YearInstant | 604000000 | JPY |
| Trade notes receivable transferred by endorsement | CurrentQuarterInstant | 636000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 53013000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 18122000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 71136000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2485000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 73622000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00913-000ElectronicsMaterialsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 90000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 90000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 53013000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 18122000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 71136000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2576000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 73712000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 12638000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 2519000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 15158000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -4000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 15154000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 55279000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 18896000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 74176000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2596000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 76772000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 217000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 217000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 55279000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 18896000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 74176000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |